Sangcopan, Saidah .

HRN: 28-08-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2025
METRONIDAZOLE 500MG (TAB)
12/19/2025
12/23/2025
ORAL
500mg
Bid X 5 Days
Sp CS
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: